378 related articles for article (PubMed ID: 12112322)
21. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
Lu Y; Zi X; Pollak M
Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
[TBL] [Abstract][Full Text] [Related]
22. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
23. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
Swarbrick A; Lee CS; Sutherland RL; Musgrove EA
Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
[TBL] [Abstract][Full Text] [Related]
24. [Changes in the activity of cyclin-kinase complexes governing cell transition from G1 phase to DNA replication phase in E1A + c-Ha-ras transformants transfected with the bcl-2 gene].
Neliudova AM; Aksenov ND; Pospelova TV
Tsitologiia; 2003; 45(2):149-57. PubMed ID: 12722479
[TBL] [Abstract][Full Text] [Related]
25. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
[TBL] [Abstract][Full Text] [Related]
26. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
27. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of p21 in MCF-7 cells is overcome by its coordinated stabilization with D-type cyclins.
Russell A; Hendley J; Germain D
Oncogene; 1999 Nov; 18(47):6454-9. PubMed ID: 10597247
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of the estrogen receptor prevents the down-regulation of p21Waf1/Cip1 in hormone dependent breast cancer cells.
Zhao H; Yu J; Peltier CP; Davie JR
J Cell Biochem; 2004 Oct; 93(3):619-28. PubMed ID: 15378598
[TBL] [Abstract][Full Text] [Related]
30. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
D'Agnano I; Valentini A; Fornari C; Bucci B; Starace G; Felsani A; Citro G
Oncogene; 2001 May; 20(22):2814-25. PubMed ID: 11420693
[TBL] [Abstract][Full Text] [Related]
31. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
Foster JS; Wimalasena J
Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
[TBL] [Abstract][Full Text] [Related]
32. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
Henri P; Prevel C; Pellerano M; Lacotte J; Stoebner PE; Morris MC; Meunier L
Br J Dermatol; 2020 Mar; 182(3):678-689. PubMed ID: 31145809
[TBL] [Abstract][Full Text] [Related]
33. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE
Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
35. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
Al-Khalaf HH; Hendrayani SF; Aboussekhra A
Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1.
Collado M; Medema RH; Garcia-Cao I; Dubuisson ML; Barradas M; Glassford J; Rivas C; Burgering BM; Serrano M; Lam EW
J Biol Chem; 2000 Jul; 275(29):21960-8. PubMed ID: 10791951
[TBL] [Abstract][Full Text] [Related]
37. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression.
Obaya AJ; Kotenko I; Cole MD; Sedivy JM
J Biol Chem; 2002 Aug; 277(34):31263-9. PubMed ID: 12070150
[TBL] [Abstract][Full Text] [Related]
38. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse.
Balasubramanian S; Kim KH; Ahmad N; Mukhtar H
Oncogene; 1999 Feb; 18(6):1297-302. PubMed ID: 10022811
[TBL] [Abstract][Full Text] [Related]
39. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes.
Orlando S; Gallastegui E; Besson A; Abril G; Aligué R; Pujol MJ; Bachs O
Nucleic Acids Res; 2015 Aug; 43(14):6860-73. PubMed ID: 26071952
[TBL] [Abstract][Full Text] [Related]
40. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
Westbrook L; Manuvakhova M; Kern FG; Estes NR; Ramanathan HN; Thottassery JV
Cancer Res; 2007 Dec; 67(23):11393-401. PubMed ID: 18056467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
